A Federal Appeals Court today vacated a previous judge's ruling that the National Institute of Health’s funding could not be used for embryonic stem cell research. I do not have any competence to evaluate the Court's decision, nor do I care to argue about the ethics of human embryonic stem cell research.
My comment is simply that, to judge by the silence of my Twitter stream, health policy writers no longer care about this issue. A decade ago, human embryonic stem cell research was supposedly very important. Supporters of the right-to-life viewed the destruction of embryonic stem cells in the course of research as murder. Their opponents viewed the opportunity to do research as critical for the treatment of Parkinsons, among other disorders.
So what's different today?